BioCentury
ARTICLE | Clinical News

Agile begins Phase II

May 17, 2001 7:00 AM UTC

Agile Therapeutics (West Conshohocken, Penn.) began two Phase II trials of its 7-day transdermal contraceptive patch, which contains levonorgestrel (LNG) and ethinyl estradiol (EE). The trials will de...